Working group on pharma deals may help harmonize reviews while bringing ‘aggressive’ approach
A new transatlantic working group for mergers in the pharmaceutical sector will provide a chance to build on cooperation among regulators to help harmonize analysis, which has sometimes diverged in global...To view the full article, register now.
Already a subscriber? Click here to view full article